Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Starting soon
Conditions studied: Prostatic Neoplasms, Castration-Resistant
In brief
The goal of this predictive test is to prospectively test the performance of pre-developed artificial intelligence (AI) predictive model for predicting the time to castration resistance of prostate cancer. Investigators had developed this AI model based on deep learning algorithms in preliminary research, and it performed well in retrospective tests.
Key facts
- Study ID
- NCT07376057
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- People needed
- 150
- Starts
- 2026-01-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-01-29
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patients are diagnosed with intermediate- to high-risk prostate cancer; undergo prostate biopsy
- Patients only received endocrine therapy for prostate cancer;
- Patients with complete clinical and pathological information.
- Patients agree to participate in this diagnostic test.
You may not qualify if…
- Patients with other tumors and undergo systemic therapy .
- The patient refused to participate in this diagnostic test.
Where it is running
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.